Altogether, our study suggests that elevated EphB2 levels in the CNS of PLWH contribute to the chronic inflammation, driving at least some of the neuropathology associated with HAND, and that therapeutics targeting EphB2-mediated ephrin-B signaling in microglia may minimize these deleterious effects [17]. The gene discussed is EPHB2; the disease is HIV-associated neurocognitive disorder.